Progressive fibrosing interstitial lung diseases (ILDs) encompass a wide range of diseases, including hypersensitivity pneumonitis, occupational diseases, granulomatous diseases, drug-induced diseases ...
More clinical guidance is needed for monitoring interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA), according to a new commentary. Though ILD is a leading cause of death among ...
Neil B. Minkoff, MD: Dr Oldham, as we start to think about treatment and the different treatment paradigms, what’s available clinically and available for patients? My understanding is there aren’t ...
Optimal therapy for fibrosing alveolitis (part of the spectrum of interstitial lung disease [ILD]) has not been clearly established. To date, most treatment strategies have been based on eliminating ...
Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function. 1, 2 Affecting up to 100,000 people in the U.S. and up to 5.6 ...
Please provide your email address to receive an email when new articles are posted on . Patients treated with TNF inhibitors had respiratory hospitalization and mortality rates similar to patients on ...
Please provide your email address to receive an email when new articles are posted on . Heavy smoking, based on pack-years, in adults with progressive fibrosing interstitial lung disease was ...
After a year of treatment, patients assigned to pirfenidone lost an average 66 mL of forced vital capacity (FVC) compared with a mean 146-mL decline in the placebo group, according to Ivan Rosas, MD, ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results